Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,576 public trials 831 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients

NCT04717700

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark
  • Regionshospitalet Gødstrup Gødstrup, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Active, Not Recruiting

Gene Therapy for Haemophilia A.

NCT03001830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • St. Luke'S Regional Medical Center, Ltd Boise, Idaho, United States
  • University of Kentucky Lexington, Kentucky, United States
  • St Jude's Children's Research Hospital Memphis, Tennessee, United States
  • Royal Free Hospital London, United Kingdom
View Trial Details
Active, Not Recruiting

A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)

NCT04965155

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • AOU Policlinico di Bari Bari, Italy
  • AOU di Bologna Bologna, Italy
  • Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige Bolzano, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies

NCT04072458

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +40 more
Locations
  • Georgia Cancer Center Augusta, Georgia, United States
  • New York Medical College / Westchester Medical Center Valhalla, New York, United States
  • Sarah Cannon Research Institute/Tennesee Oncology Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

NCT04041050

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +22 more
Locations
  • City of Hope /ID# 239769 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 242558 Fullerton, California, United States
  • Moores Cancer Center at UC San Diego /ID# 229584 La Jolla, California, United States
  • UCLA /Id# 222784 Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04939142

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • The First Affiliated Hospital OF USTC Hefei, Anhui, China
  • The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
  • Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Active, Not Recruiting

Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

NCT06798805

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy
  • ASST Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori- IRST Meldola, FC, Italy
  • Ospedale S.Maria delle Croci Ravenna, RA, Italy
View Trial Details
Active, Not Recruiting

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

NCT04782687

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Maryland Oncology Hematology, P.A. Columbia, Maryland, United States
  • New York Oncology Hematology, P.C. Albany, New York, United States
View Trial Details
Active, Not Recruiting

A Trial That Compare Two Treatments in Newly Diagnosed Myeloma Patients Not Eligible for Transplant

NCT04096066

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AO "SS. Antonio e Biagio" Alessandria, Italy
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • Ospedale Mazzoni Ascoli Piceno, Italy
  • Policlinico di Bari Bari, Italy
View all 40 locations
View Trial Details

Related conditions